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Abstract
Background: The use of Specific Pathogen Free (SPF) eggs in combination with RCAS retrovirus, a member of the
Avian Sarcoma-Leukosis Virus (ASLV) family, is of standard practice to study gene function and development. SPF
eggs are certified free of infection by specific pathogen viruses of either exogenous or endogenous origin,
including those belonging to the ASLV family. Based on this, SPF embryos are considered to be free of ASLV viral
protein expression, and consequently in developmental research studies RCAS infected cells are routinely identified
by immunohistochemistry against the ASLV viral proteins p19 and p27. Contrary to this generally accepted notion,
observations in our laboratory suggested that certified SPF chicken embryos may endogenously express ASLV viral
proteins p19 and p27. Since these observations may have significant implications for the developmental research
field we further investigated this possibility.
Results: We demonstrate that certified SPF chicken embryos have transcriptionally active endogenous ASLV loci
(ev loci) capable of expressing ASLV viral proteins, such as p19 and p27, even when those loci are not capable of
producing viral particles. We also show that the extent of viral protein expression in embryonic tissues varies not
only among flocks but also between embryos of the same flock. In addition, our genetic screening revealed
significant heterogeneity in ev loci composition even among embryos of the same flock.
Conclusions: These observations have critical implications for the developmental biology research field, since they
strongly suggest that the current standard methodology used in experimental studies using the chick embryo and
RCAS vectors may lead to inaccurate interpretation of results. Retrospectively, our observations suggest that studies
in which infected cells have been identified simply by pan-ASLV viral protein expression may need to be
considered with caution. For future studies, they point to a need for careful selection and screening of the chick
SPF lines to be used in combination with RCAS constructs, as well as the methodology utilized for qualitative
analysis of experimental results. A series of practical guidelines to ensure research quality animals and accuracy of
the interpretation of results is recommended and discussed.
Background
The chicken embryo has historically been the animal
model par excellence to study vertebrate development,
and its potential was significantly enhanced with the
generation of the RCAS retrovirus vectors [1,2]. Among
the main characteristics that make these vectors so
useful for developmental studies are: i) ability to effi-
ciently infect proliferating cells; ii) integration in the
genome of infected cells; and iii) ability to efficiently
replicate [3]. As a result, RCAS vectors offer a powerful
system ensuring long-terme x p r e s s i o no ft h eg e n eo f
interest and its transmission to daughter cells, coupled
to the production of new replication competent viral
particles that rapidly spread infection to proliferating
neighbor cells.
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with a Splice acceptor) are laboratory-derived vectors engi-
neered from the Rous Sarcoma Virus (RSV), a naturally-
derived retrovirus originated from the Avian Leukosis
Virus (ALV) [3]. Members of the Avian Sarcoma-Leukosis
Virus (ASLV) family, which include the ALVs, RSVs and
RCAS viruses, are classified into 6 subgroups (A-E and J)
based on antigenic characteristics of their envelope (env)
glycoproteins. They are also classified as being either exo-
genous or endogenous; thus ASLV subgroups A-D and J
are “exogenous”: naturally occurring viruses that can be
transmitted either vertically from dam to progeny through
the egg, or horizontally from bird to bird, while members
of the ASLV subgroup E are “endogenous” viruses: copies
of exogenous retroviruses that have been integrated into
the host germ line cells and are transmitted genetically in
a Mendelian fashion [4]. All members of the ASLV family
share highly similar sequences for all the viral proteins
except for the region encoding the subgroup specific gp85
surface envelope glycoprotein, which determines the
ASLV subgroup classification and subgroup infection-
specificity [4].
Endogenous proviruses of the ASLV family are
encoded by the so-called endogenous viral (ev) loci [5].
Most chicken strains contain ev loci, and in the particu-
lar case of White Leghorn chickens, the strain most
commonly used in developmental studies, more than 20
different ev loci (ev-1 through ev-23) have been already
identified [6-8]. Most of these ev loci are structurally
incomplete and therefore do not encode all sequences
necessary for production of infectious ASLVE viral par-
ticles [6-8]. White Leghorn chickens free of ev loci are
extremely rare. As reported by Zhang and colleagues
[9], there are only three known chicken lines free of
ev loci: the East Lansing Line 0 and Line 0.TVB*S1,
both from the US Department of Agriculture, and the
Canadian line WG.
Developmental biologists utilizing the chicken model
system routinely use eggs designated as “Specific Patho-
gen Free” (SPF), which are derived from controlled
breeding flocks certified free of infection by specific
pathogen viruses, including those belonging to the
ASLV family. In such studies, the use of SPF embryos is
required for at least three main reasons: i) in an
infected cell, expression of the envelope glycoprotein
blocks the receptors on the surface of the cell, inducing
the so called ‘receptor interference’ response. Thus, pre-
infection by exogenous ASLV viruses will preclude subse-
quent infection with experimental RCAS viruses of the
same subgroup [3]; ii) retroviruses readily recombine
with closely related retroviruses of either exogenous or
endogenous origin, thus raising the possibility of unde-
sirable recombination events between the RCAS vector
and ASLV viruses [3]; and iii) experimentally RCAS-
infected cells are routinely identified by expression of
viral proteins such as p19 or p27, which are also
expressed by all members of the ASLV family [4].
Therefore, pre-infection with ASLV virus would interfere
with proper identification of RCAS infected cells and/or
tissues. Therefore, the fact that most available chicken
lines, including SPF lines, have ev loci in their genome
that could produce endogenous viral proteins in addi-
tion to the ectopically expressed RCAS-derived proteins,
is of direct relevance to this line of work.
During a series of experiments designed to overexpress
different genes of interest by RCAS viral transduction, we
observed what appeared to be endogenous expression for
the viral proteins p19 and p27 in untreated SPF embryos.
Here we demonstrate that certified SPF chicken embryos
have transcriptionally active ev loci capable of expressing
ASLV viral proteins such as p19 and p27 to levels detect-
able by immunohistochemical analysis even when those
loci are not capable of producing complete infectious
viral particles. We also show that the extent of viral pro-
tein expression in embryonic tissues varies not only
among flocks but also between embryos of the same
flock. In addition, our genetic screening revealed signifi-
cant heterogeneity in ev loci composition even among
embryos of the same flock. The main purpose of this
report is to raise awareness among developmental biol-
ogy researchers, about the need for careful selection and
screening of the chicken SPF lines to be used in combina-
tion with RCAS constructs, as well as the methodology
utilized for qualitative analysis of experimental results. In
addition, we recommend some practical guidelines that
may help researchers ensure quality of the animals used
and accuracy of the interpretation of their results.
Methods
Animals
All procedures were performed in accordance with the
animal protocols approved by the Animal Care and Use
Committee at the Johns Hopkins University. Fertilized
White Leghorn SPF certified eggs were obtained from
three different commercial breeders and are arbitrarily
referred herein as flocks 1 to 4: Flocks 1 and 4, Sunrise
Farms, Catskill, NY; Flock 2, Hy-Vac, Adel, Iowa; and
Flock 3, Charles River, North Franklin, Connecticut.
Embryos were incubated in the laboratory at 37°C and
60% humidity in forced air incubator with periodic rock-
ing. Embryos were always manipulated under conditions
ensuring no possible contamination from experimental
RCAS viruses or other natural exogenous viruses: incu-
bator and working areas were kept free of possible viral
contamination by cleaning with 25% bleach; gloves were
always worn when manipulating the eggs; and RCAS-
injected eggs and non-injected eggs were kept in differ-
ent incubators.
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Nuclear localized green fluorescent protein (nucGFP)
was created by appending a 3x nuclear localization sig-
nal to the GFP C-terminus. nucGFP was then cloned
into the pENTR-D-TOPO entry vector, and transferred
into RCAS-BP-Y-DV (AddGene; Cambridge, MA) using
LR clonase. Endotoxin-free plasmids were prepared
using the Qiagen endo-free maxiprep kit. DF-1 cells
(ATCC, American Type Culture Collection, Manassas,
VA) were grown in high glucose DMEM containing 10%
FCS. To prepare virus stocks, dissociated DF-1 cells
from one 60 mm dish were resuspended in 3 ml of
DMEM and 1 ml of transfection mix (8 μgo fR C A S
plasmid DNA and 20 μl of Lipofectamine 2000 in
DMEM). Cells were subsequently incubated in suspen-
sion for 45 min at room temperature and seeded at high
density (80-90% confluency) in 60 mm dishes containing
DMEM 10%FCS, washed with fresh medium after 3-4
hours and split the following day into 2× 100 mm
dishes. Cells were thereafter maintained in medium con-
taining only 1% FCS. Supernatants were harvested after
2 additional days and concentrated RCAS stocks
obtained by centrifugation in Amicon Ultra-15 100 kDa
Filters (Millipore, Billerica, MA) at 3,000 g at 4°C for 30
minutes. RCAS-nucGFP virus stock (0.5-1 μl) was
injected in the neural tube of embryonic day (ED) 2.5 or
the amniotic chamber of ED6 chicken embryos. Micro-
injection was performed as described in [10] with minor
modifications. After injection, embryos were allowed to
develop until ED8, and the amniotic fluid was harvested
as described below. Viral infection was confirmed at the
time of harvesting using a fluorescent microscope (Axio-
plan2; Zeiss, Thornwood, NY) to visualize GFP fluores-
cence in cells of the amniotic membrane.
Immunohistochemistry
Embryos were decapitated and the heads processed for
immunohistochemical analysis as described [10]. Briefly,
whole heads were fixed in 4% paraformaldehyde in PBS
for 2-3 hours at room temperature, cryoprotected in a
serial sucrose gradient (7, 15 and 25% sucrose in 0.1 M
phosphate buffer) and frozen in a mixture of 25%
sucrose and OCT (2:1; Ted Pella, Redding, CA). Immu-
nohistochemistry (IHC) was carried out in 10 μms e c -
tions. Serial sections, collected every fifth section and
spanning the region of the head containing the eyes,
were incubated overnight at 4°C in the presence of a
first antibody and developed for immunofluorescent
detection the following day. Antibodies and dilutions
used were as follows: AMV-3C2 mouse monoclonal
antibody raised against the ASLV viral matrix protein
p19 (1:5; NICHD-funded Developmental Studies Hybri-
doma Bank maintained by The University of Iowa, Iowa
City, IA); p27 rabbit polyclonal antibody raised against
the ASLV viral capsid protein p27 (1:1000; Charles River
Laboratories, Wilmington, MA). Antibody binding was
routinely detected on the second day with Alexa 594
goat anti-mouse or Alexa 488 goat anti-rabbit antibodies
(Molecular Probes, OR).
Collection and processing of Amniotic Fluid samples
Amniotic fluid samples were collected at the time of
embryo harvesting (ED) 6 to 8. Eggs were opened
through the air chamber and amniotic fluid was collected
w i t ha1m ls y r i n g ea n da2 6g a u g e×3 / 8 ” needle. To
ensure sterile conditions and avoid viral cross-
contamination, eggs were wiped clean with alcohol
wipes, forceps and scissors were flamed after each har-
vested embryo, and new sterile syringes and needles were
used for each embryo. After collection, amniotic fluid
samples from each embryo were divided in two and pro-
cessed separately in order to obtain: i) cell-free amniotic
fluid: amniotic fluid was centrifuged at 12,000 rpm for 15
min at 4°C, and the cell-free supernatant was used imme-
diately or stored at -20°C until use; ii) cell-containing
amniotic fluid: in order to keep cellular contents in the
samples, amniotic fluid was not centrifuged and used
immediately after harvest or stored at -20°C until use.
Inoculation assay for detection of exogenous infectious
viral particles in amniotic fluid
DF-1 chicken fibroblasts cells were cultured and main-
tained according to ATCC instructions. On the day of
seeding, DF-1 cells were inoculated with 100 μl of cell-
free amniotic fluid from embryos from flocks 1-4 (n = 5
embryos/flock) or with cell-free amniotic fluid from
embryos infected with RCAS-nucGFP virus as a positive
control. Cells were passaged after 5 days in culture and
maintained for an additional 5 days. Cells were then
fixed in 4% paraformaldehyde in phosphate buffer for 20
minutes at room temperature and processed for IHC
with the AMV-3C2 and p27 antibodies. In addition, pre-
sence of ASLV infective viral particles was tested by RT-
PCR in samples of supernatant from inoculated DF-1
cells. DF-1 supernatant (1 ml) was collected 10 days
after inoculation and centrifuged at 4°C and 12,000 rpm
for 10 min to eliminate cellular content. Ten microliters
of centrifuged DF-1 supernatant were treated with
DNAseI (Invitrogen, Carlsbad, CA) and random primed
reverse transcription was carried out with cloned AMV
reverse transcriptase (Invitrogen, Carlsbad, CA); both
reactions were performed according to the manufacturer
instructions. Samples lacking AMV reverse transcriptase
were run in parallel to control for possible “false posi-
tives” from DNA amplification. Two μl of RT-reaction
product were used as template for PCR amplification
with primers targeting the hypervariable region 1i nt h e
gp85 env gene, which is common to all ASLV subgroups
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Table 1 and Figure 1). PCR amplification was carried
out with an initial cycle at 94°C for 2 min, followed by
40 cycles at 94°C for 30s, 60°C for 30s, and 72°C for
45 s and a final extension cycle at 72°C for 7 min.
RT-PCR assay for detection of endogenous infectious viral
particles in amniotic fluid
Cell-free amniotic fluid from embryos from flocks 1-4 (n
= 5 embryos/flock) was assayed by RT-PCR for the
detection of endogenous viral particles. Embryos
infected with RCAS-nucGFP virus were used as positive
controls (n = 5). Ten microliters of centrifuged amniotic
fluid were treated with DNAseI (Invitrogen, Carlsbad,
CA) and random primed reverse transcription was car-
ried out with cloned AMV reverse transcriptase (Invitro-
gen, Carlsbad, CA); both reactions were performed
according to the manufacturer instructions. Samples
lacking AMV reverse transcriptase were run in parallel
to control for possible “false positives” from DNA
amplification. Two μl of reverse transcribed reaction (or
reactions lacking reverse transcriptase) were used as
template for PCR reactions designed to amplify regions
common to all ASLV subgroups, including endogenous
ALV-E and RCAS constructs (primer sets U1 and U2,
Table 1 and Figure 1). Amplification with the U1 primer
set was done as described above. For the U2 primer set
a “touch down” PCR program with the following para-
meters was used: 14 rounds of PCR using 1 min dena-
turation at 93°C, 1 min annealing beginning at 60°C and
decreasing 1°C in each cycle, and 1 min 30s extension at
72°C; followed by 30 cycles of 93°C for 1 min, 48°C for
1 min, 72°C for 1 min 30s.
Polymerase Chain Reaction screening for ASLV ev loci
Ten μl of cell-containing amniotic fluid samples from
embryos from flocks 1-4 (n = 5-8 embryos/flock) were
used as template for PCR screening of ev loci composi-
tion. Three sets of primers were used to target different
regions of the ev loci: i) the region corresponding to the
p27 protein; ii) a 200 bp region of the pol-env junction;
and iii) a region of the gp85 glycoprotein specific for
subgroup E (P27, U2 and E respectively, Table 1 and
Figure 1). For the P27 and E primer sets PCR amplifica-
tion was carried out with an initial cycle at 94°C for 2
min, followed by 40 cycles at 94°C for 30s, 60°C for 30s,
and 72°C for 45 s and a final extension cycle at 72°C for
7 min. For U2 primers the ‘touch down’ PCR program
described in the previous section was used.
Results
SPF chicken embryos expressed ASLV-related viral
proteins
Immunohistochemical analysis of head sections revealed
endogenous expression of both, p19 and p27 viral pro-
teins in embryos from 3 of the 4 flocks tested (Table 2).
The percentage of embryos that tested positive for p19
and p27 varied among these flocks, ranging from 33% to
100% (Table 2). In addition, the extent of viral protein
expression also varied between the different flocks.
Table 1 List of primers used in this study and target ASLV regions and subgroups
Primer Target
Region
Target ALV
subgroup
Forward Primer
5’-3’
Reverse Primer
5’-3’
Product size
(bp)
Reference
U1 gp85 env A, B, C, D, J and E CTRCARCTGYTAGGYTCCCAGT
1 GYCAYCACTGTCGCCTRTCCG
1 229 [14]
U2 pol-env A, B, C, D, J and E GGATGAGGTGACTAAGAAAG GGGAGGTGGCTGACTGTGT 295-326
2 [24]
E gp85 E env E GGCTTCGCCCCACACTCCAA GCACATCTCCACAGGTGTAAAT 265 [14]
P27 p27 protein A, B, C, D, J and E CAGGCCGCATTATTAAGACC TGGCTGTGACTTCTGCTGCCT 240 This study
1R = A/G; Y = T/C.
2Exact size depends on the ALV subgroup.
Figure 1 ASLV genomic organization and target sites for primers used in this study. This diagram represents the generic organization of
ASLV viruses for the gag (blue) pol (green) and env (grey) genes and their respective subunits for proteins p19, p2, p10, p27, NCp12, PRp15,
reverse transcriptase, integrase and gp85. Target sites for the primers are indicated by green triangles, dark green for forward and light green for
reverse primers. The U1, U2 and P27 primer sets detect all viral subgroups, while the E primer set binds only to viruses of the E subgroup. Since
differences exist between viral subgroups and even within members of the same subgroup this diagram is not drawn to scale.
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and p27 showed extensive expression in the retina, brain
and cephalic mesenchyme (Figure 2A-D) while embryos
from flock 4 showed a much more restricted expression
pattern, confined to discrete columns in the retina,
sometimes with as few as 2 to 3 cells per column (Fig-
ure 2E and 2F) and small regionally restricted areas of
the brain (Figure 2I and 2J). It is worth noting that pro-
cessing of several serial sections per embryo was critical
in order to identify these very discrete areas of endogen-
ous viral protein expression in embryos from flock 4. In
addition, embryos from flocks 1 and 2, but not 3 and 4,
showed significant expression of viral proteins in the
lens (Figure 2G). In all the flocks that tested positive for
viral proteins, the pattern of expression in the retina
and lens resembled the columnar pattern characteristic
of retroviral infection in these tissues (Figure 2). Double
labeling IHC confirmed co-expression of p19 and p27
protein in all cases (Figure 2H).
SPF embryos expressing ASLV viral proteins were
negative for exogenous and endogenous ALV infective
viral particles
These observations suggested that embryos from at least
three of the flocks under study may have been either i)
pre-infected by exogenous ASLV or ii) have an ev loci
capable of producing infectious endogenous viral parti-
cles. In order to rule out the first possibility, we
designed a series of experiments directed at identifying
live exogenous viral particles in the amniotic fluid of the
chick embryos. For this purpose, we took advantage of
the DF-1 cell line, a chicken fibroblast cell line derived
from the chicken endogenous ev loci-free East Lansing
Line 0 (also known as ELL-0 or EV-0 line). Since these
cells do not express the subgroup E membrane receptor
TVB*S1, they are resistant to ALVE but susceptible to
infection from all exogenous ASLV subgroups [9,11-13].
DF-1 cells were inoculated with 100 μl of amniotic fluid
from embryos from flocks 1-4 (n = 5/flock) or with
amniotic fluid from positive control embryos infected
with RCAS-nucGFP virus. Similar to untreated control
DF-1 cells (Figure 3A), cells inoculated with amniotic
fluid from embryos from flocks 1-4 were negative for
p19 or p27 viral proteins, with the exception of those
inoculated with amniotic fluid from RCAS-nucGFP
infected embryos (Figure 3B-C). In order to rule-out the
possibility of viral infection below the level of immuno-
histochemical detection, we also carried out the more
sensitive RT-PCR assay for detection of ASLV viral par-
ticles in the supernatant of amniotic fluid-inoculated
DF-1 cells. In agreement with the immunohistochemical
results, RT-PCR with a pan-ASLV primer set (recogniz-
i n ga l le x o g e n o u sA S L Vs u b g r o u p sa n dR C A Sv i r u s ,
Table 1 and Figure 1) was negative in all cases with the
exception of positive controls (Figure 3D). Taken
together, these results provide compelling evidence that
embryos from flock 1-4 were not pre-infected with exo-
genous ASLV viruses.
The next step was to test whether SPF chick embryos
were producing viral particles from endogenous ev loci.
Since the previous set of experiments clearly showed
that SPF embryos were devoid of infection by exogenous
ASLVs, detection of ASLV viral RNA in fluid-compo-
nents of the eggs would indicate production of endogen-
ous viral particles. Current techniques involve RNA
purification from egg albumin samples for RT-PCR
screening [14]. This approach, however, requires cum-
bersome procedures due to coagulation of albumin pro-
teins and may also lead to false negatives as a
consequence of possible low yield RNA recovery during
purification [14]. In order to overcome these limitations,
we developed an assay to test for viral particles directly
from amniotic fluid samples. We reasoned that the
amniotic fluid of embryos infected with viruses should
contain viral particles, and that since amniotic fluid is
98-99% water [15] it should be compatible with RT-PCR
reactions without the need for RNA isolation. In order
to eliminate cells and DNA content from the amniotic
fluid, samples were centrifuged and treated with DNAse
as described in Methods. Cell-free amniotic fluid was
used as template for RT-PCR detection of viral RNA
with primers recognizing all ASLV subgroups, including
the endogenous ALVE subgroup and the related RCAS
virus (Table 1 and Figure 1). Successful amplification
from amniotic fluid of embryos infected with RCAS-
nucGFP, even in the case of embryos injected only 24
hours before amniotic fluid harvest, demonstrated the
efficiency and sensitivity of the new assay (Figure 3, E).
In contrast, amplification products from amniotic fluid
samples from flocks 1-4 were consistently negative,
including embryos that were positive for immunohisto-
chemical detection of p19/p27 proteins (Figure 3E).
Thus, although viral proteins could be detected in tis-
sues of a significant percentage of embryos from flocks
1-4, there was no evidence of viral particle production.
Table 2 Immunohistochemical detection of endogenous
viral proteins in SPF embryos
Flock Total n p27/p19 (+) % of (+) embryos
1 84 5 0
2 4 4 100
3 60 0
4 93 3 3
Serial sections (1 every 5/embryo) were processed by immunohistochemical
detection of endogenous p27 and p19 viral proteins. Three of the four flocks
tested showed embryos positive for endogenous viral expression. The
percentage of positive embryos varied among the flocks. In all positive
embryos, p27 and p19 were co-expressed.
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Page 5 of 11Figure 2 Immunohistochemical detection of ALV viral proteins in certified SPF chicken embryos. (A-D) Transversal sections of ED6 chick
embryo heads, processed by IHC against p27 viral protein (A and C) and DAPI (B and D). (A-B) Section corresponding to an embryo from Flock
1 that was negative for endogenous viral protein expression. (C-D) Section corresponding to a similar region of another embryo from Flock 1,
showing extensive expression of p27 viral protein in the retinal neuroepithelium (rn), surrounding cephalic mesenchyme (cm) and brain
neuroepithelium (bn) (vc: vitreal cavity). (E and F) Transversal sections of the retina of two different ED11 embryos from Flock 4 showing discrete
columns of p27 positive cells; notice in F that in some cases only a few cells are positive for endogenous viral proteins (onl: outer nuclear layer;
inl: inner nuclear layer; gcl: ganglion cell layer). (G) Transversal section through the lens of an ED6 embryo from Flock 2 showing endogenous
expression of p27 viral protein (le: lens; dc: developing cornea). (H) Transversal section of the retina of an ED6 embryo from Flock 1 showing co-
expression of p19 (red) and p27 (green) (rn: retinal neuroepithelium; vc: vitreal cavity). Notice the columnar pattern of expression, particularly in
the retinal neuroepithelium and the lens. (I-J) Transversal section through the brain of an ED11 embryo from Flock 4; (I) bright field image; (J)
immunostaining for p27 viral protein. Small, well defined areas of the developing brain (br) showed positive expression of p27 (arrows); these
areas showed a symmetrical pattern, being present in both, right and left brain structures (vc: ventricular cavity). Scale bar in (J) corresponds to
150 μm for A-D; 100 μm for E-F and H; 250 μm for G and 450 μm for I-J.
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the inoculation assays, and further confirmed that
embryos from flocks 1-4 were not pre-infected with exo-
genous ALV viruses. In addition, these results also
demonstrated that the embryos were not producing viral
particles from endogenous ev loci.
Genetic screening demonstrated that SPF embryos have
ev loci encoding the p27 viral protein
The observation that SPF embryos were not infected by
either exogenous or endogenous ASLV virus, contrasts
with our findings showing detection of ASLV viral pro-
tein in vivo by IHC. This apparent contradiction likely
suggests that expression of the viral proteins in tissues
may, in some cases, be independent of the production
of viral particles. We therefore reasoned that although
the ev loci present in embryos from the flocks analyzed
might not be capable of generating viral particles, they
may still be capable of producing viral proteins such as
p27 and p19. This premise prompted further molecular
analysis of their genomic composition. Since amniotic
fluid normally contains embryonic cells, we decided to
use amniotic fluid samples with no centrifugation or
DNAse treatment to screen for the presence of three
different regions of the ev loci in the genome of embryos
from flocks 1-4 by PCR amplification. Primers were
designed to target: i) the region corresponding to the
p27 protein; ii) a 200 bp region of the pol-env junction;
and iii) a region specific for the subgroup E viral envel-
ope (P27, U2 and E respectively, Table 1 and Figure 1).
Results are summarized in Table 3. All three ev loci
regions were observed in all flocks analyzed and they
showed a similar pattern across flocks, with a subpopu-
lation of embryos with ev loci containing all three
regions, and other subpopulations with variable combi-
nations of two or only one of the regions included in
this screening. Strikingly, almost all the embryos tested
(25/26) were positive for the p27 ev loci region. Most
importantly, these results demonstrated a high level of
heterogeneity of the ev loci genotype among embryos of
the same flock. As also shown in Table 3, we could not
determine any obvious correlation between presence or
absence of the ev loci regions analyzed by RT-PCR and
detection of p27 expression by IHC.
Discussion
The results of this study can be summarized as follows:
i) expression of endogenous ASLV viral proteins p19
and p27 in tissues was detected in certified SPF chicken
embryos; ii) the extent of viral protein expression as
well as the percentage of positive embryos varied among
the different flocks analyzed; iii) the pattern of viral pro-
tein expression in retina and lens resembled the colum-
nar pattern characteristic of retroviral infection in these
tissues; iv) SPF embryos expressing ASLV viral proteins
in tissues were negative for exogenous and endogenous
ASLV infective viral particles; v) genetic screening
demonstrated that SPF embryos from all flocks analyzed
contained several ev loci regions; vi) ev loci composition
varied significantly between flocks and between embryos
of the same flock; and vii) almost all the embryos tested
(25/26) were positive for the p27 ev loci region.
Figure 3 Detection of infective ASLV viral particles in amniotic fluid from SPF chicken embryos.( A-D) Inoculation assay for detection of
exogenous ASLV infection. DF-1 chicken fibroblast cells cultured in the presence of (A) no amniotic fluid; (B) amniotic fluid from untreated SPF
chicken embryo; and (C) amniotic fluid from SPF chicken embryo infected with RCAS-nucGFP construct. Inoculated cells were processed for
immunohistochemical detection of ASLV viral protein p27 (red) and counterstained with DAPI (blue). Lack of immunohistochemical signal in cells
inoculated with amniotic fluid from SPF untreated embryos (B) suggested that SPF embryos were not pre-infected with exogenous ASLV virus.
(A) and (C) were used as negative and positive controls respectively. af: amniotic fluid. Scale bar:20 μm. (D). RT-PCR analysis of supernatants from
(-) non-inoculated DF-1 cells; or DF-1 cells inoculated with (+) amniotic fluid from SPF embryos infected with RCAS-nucGPF; or (1-3) untreated
SPF embryos, confirmed absence of exogenous viral infection in SPF embryos. (E) Detection of endogenous infective viral particles directly from
amniotic fluid. Amniotic fluid from (+) SPF embryos infected with RCAS-nucGPF; or (1) untreated SPF embryos negative for p19/p27 by IHC; or (2-
3) untreated SPF embryos positive for p19/p27 by IHC, was used for direct RT-PCR detection of infective ASLV viral particles. Positive RT-PCR
amplification from amniotic fluid from embryos purposely infected with RCAS-nucGFP (+) set proof-of-principle for the approach. On the other
hand, lack of RT-PCR amplification in amniotic fluid from SPF untreated embryos further demonstrated absence of both, exogenous and
endogenous ASLV infective viral particles. (-) RT-PCR negative control.
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ASLV virus by screening for expression of the p27 pro-
tein using a standard enzyme-linked immunosorbent
assay (ELISA) [8,16]. This technique allows detection of
infectious viral particles present in biological fluids such
as meconia, swab exudates, blood, serum and albumin
from ASLV infected chickens [16]. However, commer-
cial breeders use ELISA tests according to vaccine pro-
duction standards [17], which do not necessarily ensure
eggs suitable for research using RCAS retroviruses. In
most commercial breeders, all birds are bled when a col-
ony is established, and thereafter only 5% of the birds
are bled each month; blood samples are pooled together
and the resulting serum samples are screened for anti-
bodies to the relevant pathogens [17]. Therefore, while
t h i sa p p r o a c hm a yb eu s e f u lf o rt h ed e t e c t i o no fh i g h
viral titers associated with widespread exogenous ASLV
infection, it may not be sensitive enough as to detect a
few positive embryos among the tested pool. Addition-
ally, the genome of nearly all chickens contains various
DNA proviral insertions belonging to the subgroup E
ASLV. Only a few chicken lines are free of ev loci [9],
and unfortunately, most producers of SPF eggs do not
use these lines because their egg production, fertility
and embryo survival are significantly inferior [7,18].
Our study demonstrates that most commercial SPF
chicken strains contain transcriptionally active ev loci.
Three out of the four SPF chicken flocks tested in this
study were positive for ASLV viral proteins p19 and
p27, even though they were negative for infectious viral
particles by ELISA (as certified by the breeders) and our
own analyses by RT-PCR in amniotic fluid samples and
supernatant from inoculation assays. The importance of
these observations for the developmental research com-
munity is highlighted by the fact that, based on a survey
of the literature over the last 10 years, about 60% of the
articles in which SPF chick embryos and RCAS vectors
were used, based their analyses and conclusions upon
identification of infected cells/tissues by IHC for viral
proteins p19 and p27. These studies were done under
the assumption that, since SPF chick embryos are certi-
fied to be free of ASLV viral infection, they should not
express viral proteins in tissues. Contrary to this, our
results demonstrate that lack of ASLV viral infectious
particles does not necessarily correlate with lack of viral
protein expression in SPF chick embryo tissues.
The ability of some ev loci to express viral proteins to
detectable levels by IHC in the absence of infectious
viral particles, makes it imperative that researchers
understand the biology of these events and its conse-
quences for the research field. Some aspects of the biol-
ogy of ALVE retroviruses that are particularly relevant
in this context are as follows:
i) ALVE loci in White Leghorn Chickens include at
least 23 known loci consisting of both defective and
non-defective retroviral inserts, ranging from a single
LTR region such us ALVE15,t of u l ll e n g t hr e t r o -
virus genomes such as ALVE1, 2, 7, 10, 11, 12, 14
and 21 ([8] and references therein).
ii) Expression of a given ev locus,a sw e l la si t sl e v e l
of expression, depends on several factors such as the
completeness of the proviral genome, its site of inte-
gration and epigenetic modifications. The ALV1
locus for example, although present in most White
Leghorn Chicken lines is normally silent; however
under certain conditions, such as treatment with
methylation inhibitors, ALV1 is capable of producing
viral particles [19].
Table 3 Detection of genomic ev loci regions in SPF
embryos by PCR
Flock Embryo p27 region Pol-env junction Gp85 E env IHC
1+ + + n a
2+ - - n a
1 3+ + - n a
4- - - n a
5+ + - n a
1+ + + +
2+ - - +
2 3+ + - n a
4+ + - n a
5+ + + n a
6+ + - n a
1+ + - -
2+ + + -
3+ + + -
3 4+ + + -
5+ + + -
6+ + + n a
7+ - + n a
8+ + - n a
1+ + - -
2+ - - +
3+ + + -
4 4+ + + +
5+ + + -
6+ + - +
7+ + + -
Amniotic fluid samples were used to screen for the presence of three
different regions of the ev loci by PCR. Presence of these sequences in the
genome varied between flocks and between embryos among the same flock.
Some embryos showed all three ev loci regions while others showed different
combinations of two or only one of the regions. Twenty-five out of twenty-six
embryos were positive for the p27 DNA region. No obvious correlation
between composition of ev loci and detection of p27 expression by
immunohistochemistry could be determined. IHC: immunohistochemistry. na:
not available.
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found is also important in determining its expression.
SPF chicken lines can be fixed (every individual in the
population has the same allele at a particular locus),
segregating (different alleles are present in different
individuals of the population), or both, for several differ-
ent ev loci as well as for the TVB* loci, which encode
t h ed i f f e r e n tA S L V Em e m b r a n er e c e p t o r sT V B * S 1 ,
TVB*S3 and TVB*R [8]. Breeding of chickens with dif-
ferent genetic background may give rise to higher levels
of ev loci expression, and even de-novo production of
infectious viral particles. The chicken line 0.44-VB*S1-
EV21, for example, is fixed for the ALVE 21 locus but
segregating for the TVB*S1 and TVB*S3 receptor alleles.
ALVE21 in a TVB*S3 background is essentially silent,
while in a TVB*S1 background is capable of producing
high levels of infectious viral particles [8].
The SPF breeder lines are often crossed to gain the F1
vigor needed to generate the number of fertile eggs
required by regulatory agencies [8]. The crossing of lines
fixed or segregating for different ev and/or TVB* loci,
increases the chances for stochastic genomic recombina-
tion, thus consequently increasing genomic heterogeneity
for ev loci in the chick population. Furthermore, even
within a given established chicken line, heterogeneity for
ev loci composition can give rise to variations in the
genetic background, and in turn in ev loci expression, from
flock to flock and even within a same flock. In addition,
chicken flocks have limited productivity (30-40 weeks,
[20]; B&E Eggs personal communication), which means
that even when receiving embryos of a given line and bree-
der, periodic variations in the flock source are inevitable.
Our observations demonstrating high levels of hetero-
geneity for viral protein expression in tissues as well as
for ev loci composition, even in embryos belonging to
the same flock, clearly point out the need for raising
awareness among the developmental biology commu-
n i t y .R e t r o s p e c t i v e l y ,o u rr e sults suggest that studies in
which infected cells and tissues were identified simply
by viral protein expression without controlling for possi-
ble endogenous expression of those proteins may need
to be considered with caution. As for future studies, we
recommend a series of practical guidelines to ensure
quality of research animals and accuracy of the interpre-
tation of results. The rationale and usefulness of these
guidelines are discussed below and a summarized sche-
matic representation of them is presented in Figure 4.
Practical guidelines for developmental studies involving
chicken embryos and RCAS vector
A continuous and dynamic process involving both egg
quality testing and the use of appropriate procedures
during experimental analysis is necessary.
Egg quality
i) careful characterization and selection of chicken
strains for experimental use.As o u r c e( l i n e / f l o c k )o f
research quality SPF eggs should be selected by
screening for lack, or minimal detection if otherwise
not possible, of ASLV viral particles and endogenous
viral protein expression in tissues by, for example,
RT-PCR and IHC respectively. Here we propose a
straightforward RT-PCR assay for detection of infec-
tious viral particles directly from chick amniotic
fluid that can be completed in only a few hours.
Additionally, we strongly recommend that chicken
lines be also tested for expression of viral proteins
by IHC. Based on our observations, particularly from
flocks 1 and 4, this screening should be as thorough
as possible, since analysis of a few embryos per flock
as well as analysis of a few sections per embryo may
in some cases give rise to “false negatives”. This type
of screening seems of special relevance for experi-
mental settings in which the effects of a particular
treatment is assessed in dissociated or cultured cells.
In this situation, the lack of surrounding tissues, that
make possible comparisons between RCAS infected
and contralateral non-infected structures, makes
identification of endogenous viral protein expression
almost impossible.
ii) Routine screening of SPF lines/flocks in use:R o u -
tine screening by RT-PCR and IHC is necessary to
ensure that selected lines and flocks in use do not
become ASLV positive. If at any given point, de-
novo ASLV viral particle production and/or viral
protein expression in tissues is detected, a new line
or flock should be tested and selected for further
use.
Experimental Analysis
Use of alternative methods, other than immunohisto-
chemical detection of pan-ASLV viral proteins such as
p19 and p27, for identification of experimentally infected
cells and/or tissues. Considering that the standard tests
used by SPF egg breeders are reliable in ensuring eggs
free of exogenous ASLV viruses, and that the most com-
monly used RCAS constructs belong to the exogenous
subgroups A-D, techniques such as IHC and in situ
hybridization to detect ASLV subgroup specific proteins
would be ideal. Hunter and collaborators reported the
generation of a mouse monoclonal antibody directed
against the RSV subgroup A Env protein [21], but to
our knowledge, the only subgroup specific antibodies
commercially available are the monospecific polyclonal
chicken antibodies against the RSV subgroups A and B
from Charles River. Although we were initially con-
cerned about possible non-specific staining of these
chick antisera in chick tissues, the Avian Leukosis RSV
A antisera (catalog number: 523501) has worked very
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Page 9 of 11well in our hands and we now use it routinely to detect
infected cells in experimental animals (unpublished
results; antibody concentration 1:5000). Further develop-
ment of antibodies covering the whole spectrum of
ASLV subgroups would be highly beneficial for the
research community. Alternatively, the nucleotide
sequences of the gp85 envelope region, which defines
the ASLV subgroups, have been well characterized and
can be used for designing subgroup specific probes for
in situ hybridization when appropriate antibodies are
not available ([22] and references therein).
Another alternative is to express the gene of interest
fused to an epitope tag, or to co-express it with a fluor-
escent reporter. RCAS derivatives that allow the inser-
tion of genes using the Gateway recombination cloning
system have been generated [23] and are available to the
research community from AddGene http://www.
addgene.org. Some of these constructs have been devel-
oped to allow expression of the gene of interest with an
influenza hemaglutinin (HA) epitope tag, either in the
amino (NHA) or carboxy (COOH) terminus. Alterna-
tively, co-expression of fluorescent reporters together
with the gene of interest could be considered for small
size genes, but due to inherent limitations to the carry-
ing capacity of the RCAS vector backbone (insert sizes
bigger than 2.5K are unstable, [3]) they cannot be used
for long gene coding sequences.
Conclusions
We have demonstrated that certified SPF chicken
embryos have transcriptionally active endogenous ASLV
loci capable of expressing ASLV viral proteins even
when those loci are not capable of producing infectious
viral particles. We also show that the extent of viral pro-
tein expression in embryonic tissues varies not only
among flocks but also between embryos of the same
flock. In addition, our genetic screening revealed signifi-
cant heterogeneity in ev loci composition even among
embryos of the same flock. These observations point to
the need for systematic screening of chicken lines and
flocks as well as appropriate methodology to identify
experimentally infected cells and tissues in developmen-
tal studies using the chick as the experimental model.
Acknowledgements
We thank Drs. Donald Zack and James Handa for insightful discussions
during the course of these studies. We also thank Dr. Natalia Vergara for
critical reading of the manuscript. This work was supported by NIH grants
EYO4859 (MVC-S), and Core Grant EY1765.
Authors’ contributions
MM, KJW and MVCS designed and performed experiments and analyzed the
data. MVCS wrote the paper and MM and KJW contributed with critical
reading and editing of the text. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 17 July 2010 Accepted: 18 October 2010
Published: 18 October 2010
References
1. Hollenbeck PJ, Fekete DM: Expression of transgenes in primary neurons
from chick peripheral and central nervous systems by retroviral infection
of early embryos. Methods Cell Biol 2003, 71:369-86.
Figure 4 Recommended workflow for developmental studies involving chicken embryos and RCAS vectors. SPF eggs should be selected
by screening for lack of ASLV viral particles and endogenous viral protein expression in tissues. Afterwards, routine screening of selected lines is
necessary. During experimental analysis, experimental infection should be determined by expression of viral proteins specific for the subgroup
corresponding to the RCAS vector used, or alternatively, by using expression reporters such as epitope tags or fluorescent proteins.
McNally et al. BMC Developmental Biology 2010, 10:106
http://www.biomedcentral.com/1471-213X/10/106
Page 10 of 112. Gordon CT, Rodda FA, Farlie PG: The RCAS retroviral expression system in
the study of skeletal development. Dev Dyn 2009, 238:797-811.
3. Hughes SH: The RCAS vector system. Folia Biol (Praha) 2004, 50:107-19.
4. Payne LN: Retrovirus-Induced Disease in Poultry Review. Poultry Science
1998, 1204-1212.
5. Astrin SM, Robinson HL, Crittenden LB, Buss EG, Wyban J, Hayward WS: Ten
genetic loci in the chicken that contain structural genes for endogenous
avian leukosis viruses. Cold Spring Harb Symp Quant Biol 1980, 44(Pt
2):1105-9.
6. Johnson JA, Heneine W: Characterization of endogenous avian leukosis
viruses in chicken embryonic fibroblast substrates used in production of
measles and mumps vaccines. J Virol 2001, 75:3605-12.
7. Bacon LD, Fulton JE, Kulkarni GB: Methods for evaluating and developing
commercial chicken strains free of endogenous subgroup E avian
leukosis virus. Avian Pathol 2004, 33:233-43.
8. Hunt H, Fadly A, Silva R, Zhang H: Survey of endogenous virus and TVB*
receptor status of commercial chicken stocks supplying specific-
pathogen-free eggs. Avian Dis 2008, 52:433-40.
9. Zhang H, Bacon LD, Fadly AM: Development of an endogenous virus-free
line of chickens susceptible to all subgroups of avian leukosis virus.
Avian Dis 2008, 52:412-8.
10. Canto-Soler MV, Adler R: Optic cup and lens development requires Pax6
expression in the early optic vesicle during a narrow time window. Dev
Biol 2006, 294:119-32.
11. Bacon LD, Hunt HD, Cheng HH: A review of the development of chicken
lines to resolve genes determining resistance to diseases. Poultry Science
2000, 79:1082-93.
12. Schaefer-Klein J, Givol I, Barsov EV, Whitcomb JM, VanBrocklin M, Foster DN,
Federspiel MJ, Hughes SH: The EV-O-derived cell line DF-1 supports the
efficient replication of avian leukosis-sarcoma viruses and vectors.
Virology 1998, 248:305-11.
13. Himly M, Foster DN, Bottoli I, Iacovoni JS, Vogt PK: The DF-1 chicken
fibroblast cell line: transformation induced by diverse oncogenes and
cell death resulting from infection by avian leukosis viruses. Virology
1998, 248:295-304.
14. Pham TD, Spencer JL, Johnson ES: Detection of avian leukosis virus in
albumen of chicken eggs using reverse transcription polymerase chain
reaction. J Virol Methods 1999, 78:1-11.
15. Modena AB, Fieni S: Amniotic fluid dynamics. Acta Biomed 2004, 75(Suppl
1):11-3.
16. Smith EJ, Fadly A, Okazaki W: An enzyme-linked immunosorbent assay for
detecting avian leukosis-sarcoma viruses. Avian Dis 1979, 23:698-707.
17. World Health Organization Expert Committee on Biological
Standarization. Fifty-sixth Report. Book World Health Organization Expert
Committee on Biological Standarization. Fifty-sixth Report WH Organization
ed. City 2008.
18. Gavora JS, Kuhnlein U, Crittenden LB, Spencer JL, Sabour MP: Endogenous
viral genes: association with reduced egg production rate and egg size
in White Leghorns. Poultry Science 1991, 70:618-23.
19. Conklin KF, Coffin JM, Robinson HL, Groudine M, Eisenman R: Role of
methylation in the induced and spontaneous expression of the avian
endogenous virus ev-1: DNA structure and gene products. Mol Cell Biol
1982, 2:638-52.
20. Donald D, Bell WDW Jr: Commercial Chicken Meat and Egg Production.
5th edition. Book Commercial Chicken Meat and Egg Production City: Kluwer
Academic Publishers, 5 2002.
21. Ochsenbauer-Jambor C, Delos SE, Accavitti MA, White JM, Hunter E: Novel
monoclonal antibody directed at the receptor binding site on the avian
sarcoma and leukosis virus Env complex. J Virol 2002, 76:7518-27.
22. Bova CA, Olsen JC, Swanstrom R: The avian retrovirus env gene family:
molecular analysis of host range and antigenic variants. J Virol 1988,
62:75-83.
23. Loftus SK, Larson DM, Watkins-Chow D, Church DM, Pavan WJ: Generation
of RCAS vectors useful for functional genomic analyses. DNA Res 2001,
8:221-6.
24. Smith L, Brown S, Howes K, McLeod S, Arshad S, Barron G, Venugopala K,
McKay J, Paynea L: Development and application of polymerase chain
reaction (PCR) tests for the detection of subgroup J avian leukosis virus.
Virus Res 1998, 54:87-98.
doi:10.1186/1471-213X-10-106
Cite this article as: McNally et al.: Endogenous expression of ASLV viral
proteins in specific pathogen free chicken embryos: relevance for the
developmental biology research field. BMC Developmental Biology 2010
10:106.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
McNally et al. BMC Developmental Biology 2010, 10:106
http://www.biomedcentral.com/1471-213X/10/106
Page 11 of 11